Clinical Trial Update: A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea [Phase 2]

View source ↗

Summary

Phase 2 trial comparing GT160-246 to vancomycin in patients with Clostridioides difficile infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Clostridioides Difficile-associated Diarrhea

Drugs mentioned

• GT160-246
• Vancomycin (vancomycin)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Clostridium Difficile-Associated Diarrhea, Clostridium Enterocolitis | Phase 2 | Status: COMPLETED